Adenoviral Mediated Gene Therapy for Experimental Glioma

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$632,576.00
Award Year:
1997
Program:
SBIR
Phase:
Phase II
Contract:
1 R43 CA67357-01,
Award Id:
29220
Agency Tracking Number:
29220
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
540 Avis Drive, Suite A, Ann Arbor, MI, 48108
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
John Hilfinger
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
Gliomas are the most common primary intracranial brain tumors and are thought to arise as a neoplastransformation of glial cells in the central nervous system. The prognosis for the disease is poor.surgical resection of the tumor followed by radiation or chemotherapy. This application describes analternative treatment strategies. The effectiveness of an adenovirus vector to deliver the herpes sikinase (tk) gene to inhibit selectively tumor cell growth upon receipt of ganciclovir (GCV) will beadenovirus vector will be specifically introduced into the tumor area by stereotactic injection; GCVsystemically. The plan is to optimize growth inhibition by determining the effectiveness of redosingdeveloping long term release of infectious virions into the surrounding environment.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government